Close
 Indian J Med Microbiol  
 

Figure 2: Changes of amounts of darbepoetin alfa required to maintain subnormal hemoglobin levels (10–11 g/dL) in the peripheral blood during carnitine therapy. Amounts of darbepoetin alfa required were monitored for 11 months.

Figure 2: Changes of amounts of darbepoetin alfa required to maintain subnormal hemoglobin levels (10–11 g/dL) in the peripheral blood during carnitine therapy. Amounts of darbepoetin alfa required were monitored for 11 months.